Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
3 clinical trials · Condition
◉ Watch Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
| Record | Firm | Date |
|---|---|---|
| Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas (NCT04288726) | Baylor College of Medicine | 2020-09-16 |
| Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type (NCT02560441) | Chinese Academy of Medical Sciences | 2015-09-01 |
Track Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type automatically
Every clearance here is in the API, with alerts when new ones post.